tm
Seeing Is Believing
tm
Seeing Is Believing
KPTI is currently covered by 4 analysts with an average price target of $15.02. This is a potential upside of $8.87 (144.23%) from yesterday's end of day stock price of $6.15.
Karyopharm Therapeutics's activity chart (see below) currently has 19 price targets and 25 ratings on display. The stock rating distribution of KPTI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 32.72% with an average time for these price targets to be met of 85.82 days.
Highest price target for KPTI is $56, Lowest price target is $3, average price target is $20.25.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 03-Mar-2025. First documented stock forecast 02-Jun-2015.
Currently out of the existing stock ratings of KPTI, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$-4.36 (-59.24%)
$3
2 months 6 days ago
(03-Mar-2025)
1/8 (12.5%)
$-8.59 (-74.12%)
38
Buy
$18
$10.64 (144.57%)
$18
2 months 6 days ago
(03-Mar-2025)
0/6 (0%)
$6.41 (55.31%)
Buy
$56
$48.64 (660.87%)
$7
2 months 6 days ago
(03-Mar-2025)
1/2 (50%)
$44.41 (383.18%)
12
Hold
$4
$2.69 (205.34%)
$10
1 years 9 months 2 days ago
(07-Aug-2023)
6/11 (54.55%)
$2.39 (148.45%)
305
Hold
$5
$3.69 (281.68%)
$6
2 years 3 months 29 days ago
(10-Jan-2023)
3/7 (42.86%)
$2.13 (74.22%)
225
What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KPTI (Karyopharm Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?
